Cargando…
miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
BACKGROUND: Cisplatin is a commonly used drug for the treatment of various types of malignant cancers, including ovarian cancer. However, resistance to cisplatin is still a considerable obstacle to achieve a satisfactory therapeutic effect. The purpose of this study is to develop a strategy to sensi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148417/ https://www.ncbi.nlm.nih.gov/pubmed/32308421 http://dx.doi.org/10.2147/OTT.S239425 |